Zymeworks Ownership | Who Owns Zymeworks?
Zymeworks Ownership Summary
Zymeworks is owned by 3.11% institutional investors, and 96.89% retail investors. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.25% of its assets in Zymeworks shares.
ZYME Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Zymeworks | 3.11% | - | 96.89% |
Sector | Healthcare Stocks | 47.25% | 8.01% | 44.75% |
Industry | Biotech Stocks | 45.35% | 7.81% | 46.83% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 2.24M | 3.25% | 3.35K |
HBM Healthcare Investments AG Ord | 1.70M | 2.39% | - |
iShares Russell 2000 ETF | 1.42M | 2.07% | -3.21K |
UBS (Lux) Digital Health Equity SB USD | 1.42M | 2.06% | -111.54K |
BNP Paribas Health Cr Innovtr Cl Cap | 909.61K | 1.32% | 163.00 |
BNP Paribas US Small Cap Classic R | 867.32K | 1.26% | 50.97K |
Xtrackers S&P 500 Swap ETF 1C | 774.42K | 1.12% | - |
Xtrackers S&P 500 2xLev Dly Swap ETF 1C | 632.16K | 0.92% | - |
iShares Biotechnology ETF | 594.24K | 0.86% | 99.52K |
Fidelity Small Cap Index | 571.93K | 0.83% | -14.44K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jan 08, 2024 | Galbraith Kenneth | Chair & CEO | Sell | $64.00K |
Jan 05, 2024 | Galbraith Kenneth | Chair & CEO | Sell | $193.85K |
Jan 05, 2024 | Astle Christopher | SVP & Chief Financial Officer | Sell | $48.61K |
Jan 08, 2024 | Astle Christopher | SVP & Chief Financial Officer | Sell | $16.05K |
Jan 05, 2024 | Moore Paul Andrew | Chief Scientific Officer | Sell | $79.47K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q3 | - | - |
2024 Q2 | - | - |
2024 Q1 | - | 6 |
2023 Q4 | 1 | 1 |
2023 Q2 | 1 | - |
ZYME Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools